Amgen To Present At The Cowen and Company 33rd Annual Health Care Conference

Fri Mar 1, 2013 4:02pm EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130301:nPnLA69566


THOUSAND OAKS, Calif.,  March 1, 2013  /PRNewswire/ -- Amgen (NASDAQ:AMGN) will
present at the Cowen and Company 33rd Annual  Health Care Conference on 
Wednesday, March 6, 2013, at the Boston Marriott Copley Place,  Boston, Mass.,
beginning at  9:20 a.m. EST.  Arvind Sood, vice president of Investor Relations
at Amgen, will present at the conference. Live audio of the presentation can be
accessed from the Events Calendar on Amgen's website,  www.amgen.com, under
Investors. A replay of the webcast will also be available on Amgen's website for
90 days following the event.

(Logo:   http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by bringing safe and effective
medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have
changed the practice of medicine, helping millions of people around the world in
the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and
other serious illnesses. With a deep and broad pipeline of potential new
medicines, Amgen remains committed to advancing science to dramatically improve
people's lives. To learn more about our pioneering science and our vital
medicines, visit  www.amgen.com. Follow us on  www.twitter.com/amgen.  

CONTACT: Amgen,  Thousand Oaks
Ashleigh Koss, 805-313-6151 (media)
Eric Hyllengren, 805-447-1060 (investors)  

 

SOURCE  Amgen

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.